• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods. Development of a multiplex real-time RT-PCR assay for detection of Influenza A, Influenza B, RSV and typing of the 2009-H1N1 influenz

Giuseppe

Emeritus
Development of a multiplex real-time RT-PCR assay for detection of Influenza A, Influenza B, RSV and typing of the 2009-H1N1 influenza virus. (J Virol Methods, abstract, edited)

[Source: US National Library of Medicine, (LINK). Edited.]

J Virol Methods. 2010 Mar 30. [Epub ahead of print]

Development of a multiplex real-time RT-PCR assay for detection of Influenza A, Influenza B, RSV and typing of the 2009-H1N1 influenza virus.

Hymas WC, Mills A, Ferguson S, Langer J, She RC, Mahoney W, Hillyard DR. - Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108.

A high throughput real-time RT-PCR assay was developed to amplify and detect a conserved region of the hemagglutinin gene of the 2009-H1N1 influenza A virus using a minor groove binder-conjugated hybridization probe. The assay was paired with a separate triplex real-time assay that detects influenza A via the matrix gene, influenza B and RSV in a multiplex format and compared with the Centers for Disease Control and Prevention (CDC) rRT-PCR assay using 143 samples. The 2009-H1N1 portion of the multiplex assay had 100% correlation with the CDC assay, while the triplex assay had a 99% agreement. An additional 105 samples collected from October to November 2009 were also tested using both the individual 2009-H1N1 and triplex assays. Of these 105 samples, 8 were positive for the hemagglutinin target in the H1N1 assay and negative for the matrix target in the triplex assay. Discrepant analysis revealed single nucleotide polymorphisms within the matrix gene of 2009-H1N1 virus positive samples. The limit of detection for the 2009-H1N1 assay was between 750 and 1500 copies per reaction and no cross-reactivity with other respiratory pathogens was observed. Overall, this multiplexed format proved to be sensitive, robust and easy to use and serves as a useful tool for pandemic testing.

Copyright ? 2010. Published by Elsevier B.V.

PMID: 20362006 [PubMed - as supplied by publisher]
-
------
 
Back
Top Bottom